Capital Fund Management (CFM)’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-20,300
Closed -$419K – 1977
2024
Q1
$419K Sell
20,300
-53,400
-72% -$1.14M ﹤0.01% 1894
2023
Q4
$1.99M Buy
73,700
+63,200
+602% +$1.66M 0.01% 1533
2023
Q3
$311K Buy
10,500
+100
+1% +$3.52K ﹤0.01% 1862
2023
Q2
$372K Buy
+10,400
New +$299K ﹤0.01% 1604
2021
Q4
– Sell
-17,700
Closed -$2.21M – 1687
2021
Q3
$2.21M Buy
+17,700
New +$2.1M 0.02% 892
2021
Q2
– Sell
-10,200
Closed -$1.56M – 1505
2021
Q1
$1.56M Buy
+10,200
New +$1.54M 0.02% 834

Other funds holding GH

Capital Fund Management (CFM)'s GH Position: Q2 2026 in Review

Capital Fund Management (CFM) sold out of Guardant Health (GH) in Q2 2026, closing a stake of 15,295 shares — an estimated $1.41M sold.

Capital Fund Management (CFM) first reported a position in GH in Q1 2020 and held it in 12 quarters. The position peaked at $8.46M in Q2 2023. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Capital Fund Management (CFM) reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 15,295 Guardant Health shares in Q2 2026, an estimated $1.41M.
  • Capital Fund Management (CFM) first reported a position in Guardant Health in Q1 2020 and held it in 12 quarters.
  • Capital Fund Management (CFM)'s Guardant Health position peaked at $8.46M in Q2 2023.
  • 601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.